ArticleSurgical endoscopy2026
Utility of texture and color enhancement imaging combined with acetic acid-indigo carmine for improving visibility of gastric tumors: a single-center prospective study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTexture and color enhancement imaging (TXI) is an image-enhanced endoscopy technique that facilitates gastric lesion visualization by enhancing color and texture. This study aimed to assess the tumor extent using a combination of acetic acid (AA) and indigo carmine (IC) staining (AA + IC staining) with TXI for gastric tumors.
methodsBetween March 2022 and February 2023, we prospectively enrolled 50 consecutive patients with gastric tumors treated with endoscopic resection at Toho University Omori Medical Center. We compared color differences (ΔEs) between neoplastic lesions and surrounding mucosa using white light imaging (WLI) and TXI (modes 1 and 2). Each lesion was observed using the following three approaches: conventional observation (CO); IC staining; and AA + IC staining. The primary endpoint was improved tumor visibility with increased ΔE using TXI with AA + IC.
resultsA total of 49 lesions were analyzed. The ΔE observed with TXI mode 1 (TXI-1) was significantly higher than that observed with other modes (median ΔE: 18.7 with CO, 42.8 with IC, and 51.6 with AA + IC; p < 0.001). The highest ΔE was observed using TXI-1 with AA + IC (p < 0.001). Location (upper/middle vs. lower side; p = 0.020) and gastrointestinal scope (H290Z vs. EZ-1500 vs. XZ-1200; p = 0.006) were associated with ΔEs observed using TXI-1 with AA + IC.
conclusionsThe highest color contrast between lesions and normal mucosa was observed using TXI-1 with AA + IC, indicating its potential to improve the visibility of gastric tumors.
Indexed as
Identifiers
42191959What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.